Cenobamate is a medication used in the management of partial-onset seizures in adults. It works by modulating both sodium channels and GABA receptors in the brain, making it effective in reducing the frequency of seizures. The drug is known for its high bioavailability and is typically administered orally.  

The treatment begins with a low dose, which is titrated gradually. Its safety profile includes potential risks such as QT interval shortening and somnolence, so careful monitoring is advised. It is not recommended for individuals with certain heart conditions, such as familial short QT syndrome.  

This manual consolidates the key details regarding Cenobamate from the available documentation.